Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Sep 15, 2014 at 11:35 AM EDT

ReWalk Goes From Marching to Sprinting

Shares of Rewalk Robotics surged again on Monday, following its initial public offering on Friday.

Lee Jackson | Sep 15, 2014 at 10:55 AM EDT

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

A new research report from UBS focuses on four top companies that are making great strides in treatments for patients…

Chris Lange | Sep 15, 2014 at 10:35 AM EDT

Alzheimer’s Study Results Take Avanir Back Up to Multiyear Highs

Avanir Pharmaceuticals announced positive Phase 2 results for its drug candidate AVP-923, a potential new therapy for patients with Alzheimer’s…

Jon C. Ogg | Sep 15, 2014 at 9:55 AM EDT

NPS Pharma Enters Cautionary Phase of the FDA Approval Process

NPS Pharmaceuticals traded lower on what sounded like good news. The problem is that headlines often do not reveal the…

Jon C. Ogg | Sep 12, 2014 at 9:25 AM EDT

Deep Discount for Health Care REIT Secondary Offering

Health Care REIT has joined the waves of companies looking to raise capital after strong share price gains.

Chris Lange | Sep 11, 2014 at 9:20 AM EDT

Short Sellers Remain Vigilant Against Biotechs

Short sellers are often active in biotech stocks, and we have seen some excessive short interest activity in the latest…

Chris Lange | Sep 10, 2014 at 5:09 PM EDT

Virobay Files For Initial Public Offering

ThinkstockVirobay, Inc. has filed with the Securities and Exchange Commission for an initial public offering. There were no terms given…

Chris Lange | Sep 10, 2014 at 3:02 PM EDT

Does New Data Make or Break NPS Pharmaceuticals?

ThinkstockNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is up huge in regular trading on Wednesday, due to positive preliminary results of a clinical…

Chris Lange | Sep 10, 2014 at 9:40 AM EDT

IPO Filing: Xenon Pharmaceuticals

Xenon Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.

Lee Jackson | Sep 10, 2014 at 9:30 AM EDT

5 Top Hospital Stocks to Buy Getting a Boost From the Affordable Care Act

While not flashy or super high-profile, these health care companies are expected to deliver solid earnings growth for the foreseeable…

Chris Lange | Sep 9, 2014 at 9:45 AM EDT

IPO Filing: PRA Health Sciences — from KKR

PRA Health Sciences has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.

Lee Jackson | Sep 9, 2014 at 8:30 AM EDT

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

A new report from the biotech team at Deutsche Bank fields questions from clients asking for specific stocks to buy…

Lee Jackson | Sep 8, 2014 at 9:10 AM EDT

SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks

SunTrust Robinson Humphrey opens up coverage of the biotech sector with four top biotech stocks to buy and one Neutral-rated…

Chris Lange | Sep 5, 2014 at 3:05 PM EDT

Keryx Finds Out That Not All FDA Approvals Are Great Wins

ThinkstockKeryx Biopharmaceuticals Inc. (NASDAQ: KERX) announced on Friday that it had received approval from the FDA on its most recent…

Chris Lange | Sep 5, 2014 at 10:35 AM EDT

Huntington’s Disease Orphan Drug Designation Could Rescue Prana

Prana Biotechnology saw its shares surge on Friday, on the heels of the FDA granting an orphan drug designation to…

1 … 281 282 283 284 285 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

ReWalk Goes From Marching to Sprinting

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

Alzheimer’s Study Results Take Avanir Back Up to Multiyear Highs

NPS Pharma Enters Cautionary Phase of the FDA Approval Process

Deep Discount for Health Care REIT Secondary Offering

Short Sellers Remain Vigilant Against Biotechs

Virobay Files For Initial Public Offering

Does New Data Make or Break NPS Pharmaceuticals?

IPO Filing: Xenon Pharmaceuticals

5 Top Hospital Stocks to Buy Getting a Boost From the Affordable Care Act

IPO Filing: PRA Health Sciences — from KKR

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks

Keryx Finds Out That Not All FDA Approvals Are Great Wins

Huntington’s Disease Orphan Drug Designation Could Rescue Prana

Social Security’s 2027 Raise Looks Like 3.8%. Here’s How Income Investors Give Themselves a Bigger One

Her Physical Therapist Said Medicare’s $2,480 Limit Had Been Reached. That Number Is Not a Coverage Cap.

Walmart (WMT) Stock Price Prediction: Where Our Price Target Sees the Stock Going Over the Next 12 Months

Her Physical Therapist Said Medicare’s $2,480 Limit Had Been Reached. That Number Is Not a Coverage Cap.

He "Retired" From Farming and Leased Out the Acres. Telling the Tenant What to Plant Kept Him Self-Employed.

Social Security’s 2027 Raise Looks Like 3.8%. Here’s How Income Investors Give Themselves a Bigger One

Her Physical Therapist Said Medicare’s $2,480 Limit Had Been Reached. That Number Is Not a Coverage Cap.

Health and Healthcare Articles

All Health and Healthcare Articles

ReWalk Goes From Marching to Sprinting

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

Alzheimer’s Study Results Take Avanir Back Up to Multiyear Highs

NPS Pharma Enters Cautionary Phase of the FDA Approval Process

Deep Discount for Health Care REIT Secondary Offering

Short Sellers Remain Vigilant Against Biotechs

Virobay Files For Initial Public Offering

Does New Data Make or Break NPS Pharmaceuticals?

IPO Filing: Xenon Pharmaceuticals

5 Top Hospital Stocks to Buy Getting a Boost From the Affordable Care Act

IPO Filing: PRA Health Sciences — from KKR

Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015

SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks

Keryx Finds Out That Not All FDA Approvals Are Great Wins

Huntington’s Disease Orphan Drug Designation Could Rescue Prana

Social Security’s 2027 Raise Looks Like 3.8%. Here’s How Income Investors Give Themselves a Bigger One

Her Physical Therapist Said Medicare’s $2,480 Limit Had Been Reached. That Number Is Not a Coverage Cap.

Walmart (WMT) Stock Price Prediction: Where Our Price Target Sees the Stock Going Over the Next 12 Months

Featured Reads

Her Physical Therapist Said Medicare’s $2,480 Limit Had Been Reached. That Number Is Not a Coverage Cap.

He "Retired" From Farming and Leased Out the Acres. Telling the Tenant What to Plant Kept Him Self-Employed.